Enterobacteriaceae Infections: Clinical Trials

1 trial for Enterobacteriaceae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Enterobacteriaceae Infections: new trials by email Literature Review of Enterobacteriaceae Infections trials Research Report on Enterobacteriaceae Infections

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
SYNSORB Pk, Placebo - Hemolytic Uremic Syndrome
Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1451997-07-272017-06-01

Narrower conditions

Bacterial Infections (1)  ·  Communicable Diseases (1)  ·  Escherichia coli Infections (1)  ·  Hemolytic-Uremic Syndrome (1)  ·  Immune System Diseases (1)  ·  Rare Diseases (1)  ·  Urogenital Diseases (1)

Broader conditions

Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Bacterial Infections and Mycoses (1)  ·  Blood Platelet Disorders (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infections (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)

Interventions

SYNSORB Pk (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Howard Trachtman (1)

Results publications

PMID 12966125, PMID 34219224, PMID 40277027

NIH funding

R01DK052147 (1)